Screener
Castle Biosciences CSTL Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
FAQ
- What is Castle Biosciences's net debt?
- Castle Biosciences (CSTL) reported net debt of -$27.04M in Q1 2026.
- How has Castle Biosciences's net debt changed year-over-year?
- Castle Biosciences's net debt increased by 57.6% year-over-year, from -$63.85M to -$27.04M.
- What is the long-term trend for Castle Biosciences's net debt?
- Over 4 years (2021 to 2025), Castle Biosciences's net debt has grown at a -29.4% compound annual growth rate (CAGR), from -$321.33M to -$79.71M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Castle Biosciences's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude